35 States File'Product Hopping' Lawsuit Against Indivior

by on July 6, 2017

British opiod drugmaker Indivior is facing lawsuits from 35 U.S. states alleging it employed a product hopping strategy to keep generic versions of Suboxone off the market. (Source: PharmaManufacturing.com)

Previous post:

Next post: